BridgeBio Pharma Inc (BBIO)
24.11
-0.68
(-2.74%)
USD |
NASDAQ |
Nov 14, 16:00
24.10
-0.01
(-0.04%)
After-Hours: 20:00
BridgeBio Pharma Free Cash Flow (Quarterly): 72.26M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 72.26M |
| March 31, 2024 | -221.03M |
| December 31, 2023 | -125.25M |
| September 30, 2023 | -145.66M |
| June 30, 2023 | -113.78M |
| March 31, 2023 | -144.33M |
| December 31, 2022 | -94.04M |
| September 30, 2022 | -135.92M |
| June 30, 2022 | -34.36M |
| March 31, 2022 | -161.49M |
| December 31, 2021 | -136.43M |
| September 30, 2021 | -163.02M |
| June 30, 2021 | -94.00M |
| Date | Value |
|---|---|
| March 31, 2021 | -152.73M |
| December 31, 2020 | -98.41M |
| September 30, 2020 | -132.23M |
| June 30, 2020 | -88.20M |
| March 31, 2020 | -88.40M |
| December 31, 2019 | -75.45M |
| September 30, 2019 | -50.38M |
| June 30, 2019 | -68.83M |
| March 31, 2019 | -61.57M |
| December 31, 2018 | -47.16M |
| September 30, 2018 | -38.93M |
| June 30, 2018 | -35.61M |
| March 31, 2018 | -33.13M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-221.03M
Minimum
Mar 2024
72.26M
Maximum
Jun 2024
-112.24M
Average
-125.25M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 39.52M |
| Pfizer Inc | 6.063B |
| Vertex Pharmaceuticals Inc | 1.302B |
| PTC Therapeutics Inc | -87.77M |
| Bristol-Myers Squibb Co | 5.267B |